RIJ Pharmaceutical Recalls Acetaminophen Elixir Due to Microbial Count
RIJ Pharmaceutical is recalling 228 bottles of RPC APAP Elixir due to out-of-specification microbial counts in a water sample.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a CGMP deviation regarding microbial counts in a water sample, which fits the criteria for a moderate severity recall involving low-risk contamination or voluntary precautionary measures without reported illness.
Plain-English summary
RIJ Pharmaceutical LLC is recalling 228 bottles of RPC APAP Elixir (Acetaminophen 160mg) packaged in 16 FL. OZ. (473 mL) bottles. The recall is due to Current Good Manufacturing Practice (CGMP) deviations, specifically an out-of-specification total aerobic microbial count detected in a water sample.
The affected product is identified by Lot # 47080092 with an expiration date of 08/19. The product was distributed nationwide in the USA. The FDA has classified this recall as Class II.
Consumers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- RPC APAP Elixir (Acetaminophen 160mg), Packaged in 16 FL. OZ. (473 mL) bottles, RIJ PHARMACEUTICAL CORPORATION, 40 COMMERCIAL AVENUE, MIDDLETOWN, NY, NDC 53807-129-16, UPC 353807129161
- Manufacturer
- RIJ Pharmaceutical LLC
- Category
- Drug — Liquid Oral
- Hazard
- Affected units
- 228
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 47080092
- Exp 08/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by RIJ Pharmaceutical LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · RIJ Pharmaceutical LLC
See all →- ModerateRIJ Pharmaceutical Recalls Children's Acetaminophen Elixir Due to Microbial Count
FDA (Drugs) · 2018-06-20
- ModerateRIJ Pharmaceutical Recalls Ritussin DM Due to Microbial Count Deviation
FDA (Drugs) · 2018-06-20
- ModerateRIJ Recalls Gericare Diocto Liquid Due to Microbial Count Deviation
FDA (Drugs) · 2018-06-20
- ModerateGeriCare Senna Syrup Recalled for Microbial Contamination
FDA (Drugs) · 2018-06-20
- ModerateRIJ Pharmaceutical Recalls Antacid Due to Microbial Count Deviation
FDA (Drugs) · 2018-06-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereGeritrex Recalls Diphenhydramine Oral Liquid Due to Potential Microbial Contamination
FDA (Drugs) · 2019-07-31
- SevereGeritrex Recalls Ritussin DM Due to Potential Microbial Contamination
FDA (Drugs) · 2019-07-31
- ModerateBio-Pharm Recalls Acetaminophen Oral Suspension Due to Assay Failure
FDA (Drugs) · 2014-10-29
- ModerateAPAP 500 mg Acetaminophen Recalled Due to CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateRifampin Capsules Recalled Due to Manufacturing Control Deviation
FDA (Drugs) · 2022-08-24
- ModerateAcetaminophen 500 mg tablets recalled for CGMP deviations
FDA (Drugs) · 2022-02-16